Wedbush Trims IGM Biosciences (NASDAQ:IGMS) Target Price to $22.00
IGM Biosciences (NASDAQ:IGMS – Free Report) had its price target trimmed by Wedbush from $25.00 to $22.00 in a research note issued to investors on Tuesday, Benzinga reports. The firm currently has an outperform rating on the stock. Wedbush also issued estimates for IGM Biosciences’ Q3 2024 earnings at ($0.83) EPS, Q4 2024 earnings at […]
More Stories
PJX Resources (CVE:PJX) Trading 45.5% Higher – Here’s Why
PJX Resources Inc. (CVE:PJX – Get Free Report) shares rose 45.5% on Saturday . The stock traded as high as...
MultiMetaVerse (NASDAQ:MMV) Trading Down 1% – What’s Next?
MultiMetaVerse Holdings Limited (NASDAQ:MMV – Get Free Report) dropped 1% during trading on Thursday . The company traded as low...
Global Partners (NYSE:GLP) Shares Pass Above Two Hundred Day Moving Average – Time to Sell?
Global Partners LP (NYSE:GLP – Get Free Report) shares crossed above its 200-day moving average during trading on Thursday ....
Samfine Creation Holdings Group (NASDAQ:SFHG) Shares Up 19.8% – What’s Next?
Samfine Creation Holdings Group Limited (NASDAQ:SFHG – Get Free Report) shares were up 19.8% on Thursday . The company traded...
Rubicon Technology (NASDAQ:RBCN) Stock Price Passes Above 200 Day Moving Average – What’s Next?
Rubicon Technology, Inc. (NASDAQ:RBCN – Get Free Report)’s share price passed above its 200-day moving average during trading on Thursday...
Bancorp of New Jersey (NYSEAMERICAN:BKJ) Shares Pass Above Two Hundred Day Moving Average – Here’s What Happened
Shares of Bancorp of New Jersey Inc (NYSEAMERICAN:BKJ – Get Free Report) crossed above its two hundred day moving average...